SYRESpyre Therapeutics, Inc.Mar 7, 2019Q4 2018
Read transcript →Spyre Therapeutics, Inc. (SYRE) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$104.74
+0.85%
Mkt Cap $9.59B
SYRESpyre Therapeutics, Inc.Mar 7, 2019SYRESpyre Therapeutics, Inc.Mar 23, 2017Q4 2016
Read transcript →